These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9886892)
21. Obesity is associated with increased levels of circulating hepatocyte growth factor. Rehman J; Considine RV; Bovenkerk JE; Li J; Slavens CA; Jones RM; March KL J Am Coll Cardiol; 2003 Apr; 41(8):1408-13. PubMed ID: 12706940 [TBL] [Abstract][Full Text] [Related]
22. Circulating level of hepatocyte growth factor predicts incidence of type 2 diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA). Bancks MP; Bielinski SJ; Decker PA; Hanson NQ; Larson NB; Sicotte H; Wassel CL; Pankow JS Metabolism; 2016 Mar; 65(3):64-72. PubMed ID: 26892517 [TBL] [Abstract][Full Text] [Related]
23. Annual deterioration of renal function in hypertensive patients with and without diabetes. Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063 [TBL] [Abstract][Full Text] [Related]
24. Fixed-dose telmisartan/hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in decreasing serum hepatocyte growth factor and improving endothelial dysfunction in hypertensive patients. Hu ZP; Wang BN; Qian HY; Zhou Q; Wei W; Wang Y Int Heart J; 2010 Jul; 51(4):252-8. PubMed ID: 20716842 [TBL] [Abstract][Full Text] [Related]
25. Bone remodelling markers in hypertensive patients with and without diabetes mellitus: link between bone and glucose metabolism. Feldbrin Z; Shargorodsky M Diabetes Metab Res Rev; 2015 Oct; 31(7):752-7. PubMed ID: 26044709 [TBL] [Abstract][Full Text] [Related]
27. A comparison of the levels of hepatocyte growth factor in serum in patients with type 1 diabetes mellitus with different stages of diabetic retinopathy. Nowak M; Wielkoszyński T; Marek B; Kos-Kudła B; Swietochowska E; Siemińska L; Kajdaniuk D; Głogowska-Szelag J; Nowak K Endokrynol Pol; 2008; 59(1):2-5. PubMed ID: 18335393 [TBL] [Abstract][Full Text] [Related]
28. Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor. Morishita R; Higaki J; Hayashi SI; Yo Y; Aoki M; Nakamura S; Moriguchi A; Matsushita H; Matsumoto K; Nakamura T; Ogihara T Diabetologia; 1997 Sep; 40(9):1053-61. PubMed ID: 9300242 [TBL] [Abstract][Full Text] [Related]
29. Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus. Konya H; Miuchi M; Satani K; Matsutani S; Tsunoda T; Yano Y; Katsuno T; Hamaguchi T; Miyagawa J; Namba M World J Diabetes; 2014 Oct; 5(5):678-88. PubMed ID: 25317245 [TBL] [Abstract][Full Text] [Related]
30. Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes. Morishita R; Nakamura S; Nakamura Y; Aoki M; Moriguchi A; Kida I; Yo Y; Matsumoto K; Nakamura T; Higaki J; Ogihara T Diabetes; 1997 Jan; 46(1):138-42. PubMed ID: 8971094 [TBL] [Abstract][Full Text] [Related]
31. Metabolism of hepatocyte growth factor in the heart in patients with coronary artery disease: implication for coronary arteriosclerosis. Watanabe K; Fukuda H; Sueda S; Funada J; Kitakaze M; Sekiya M Cardiovasc Drugs Ther; 2001 Mar; 15(2):147-53. PubMed ID: 11669408 [TBL] [Abstract][Full Text] [Related]
32. Estimation of transforming growth factor-beta 1 as a marker of renal injury in type II diabetes mellitus. Ibrahim S; Rashed L Saudi Med J; 2007 Apr; 28(4):519-23. PubMed ID: 17457470 [TBL] [Abstract][Full Text] [Related]
33. Serum hepatocyte growth factor concentration in obese women decreases after vertical banded gastroplasty. Swierczynski J; Korczynska J; Goyke E; Adrych K; Raczynska S; Sledzinski Z Obes Surg; 2005; 15(6):803-8. PubMed ID: 15978151 [TBL] [Abstract][Full Text] [Related]
34. Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria. Gasic S; Wagner OF; Fasching P; Ludwig C; Veitl M; Kapiotis S; Jilma B Am J Hypertens; 1999 Feb; 12(2 Pt 1):217-22. PubMed ID: 10090351 [TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor plays a key role in insulin resistance-associated compensatory mechanisms. Araújo TG; Oliveira AG; Carvalho BM; Guadagnini D; Protzek AO; Carvalheira JB; Boschero AC; Saad MJ Endocrinology; 2012 Dec; 153(12):5760-9. PubMed ID: 23024263 [TBL] [Abstract][Full Text] [Related]
36. Production and activation of hepatocyte growth factor in acute renal failure. Sugimura K; Goto T; Tsuchida K; Takemoto Y; Kim T; Kishimoto T Ren Fail; 2001; 23(3-4):597-603. PubMed ID: 11499573 [TBL] [Abstract][Full Text] [Related]
37. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease. Shao Y; Ren H; Lv C; Ma X; Wu C; Wang Q Endocrine; 2017 Jan; 55(1):130-138. PubMed ID: 27522360 [TBL] [Abstract][Full Text] [Related]
38. Effectiveness of Intracavernous Delivery of Recombinant Human Hepatocyte Growth Factor on Erectile Function in the Streptozotocin-Induced Diabetic Mouse. Das ND; Yin GN; Choi MJ; Song KM; Park JM; Limanjaya A; Ghatak K; Minh NN; Ock J; Park SH; Kim HM; Ryu JK; Suh JK J Sex Med; 2016 Nov; 13(11):1618-1628. PubMed ID: 27770854 [TBL] [Abstract][Full Text] [Related]
39. Endogenous digoxin-like immunoactivity in subjects with diabetes mellitus and hypertension. Martinka E; Ocenásová A; Kamenistiaková L; Dobrota D; Kerný J; Mokán M Am J Hypertens; 1998 Jun; 11(6 Pt 1):667-76. PubMed ID: 9657625 [TBL] [Abstract][Full Text] [Related]
40. Correlation between changes in inflammatory cytokines and the combination with hypertension in patients with type 2 diabetes mellitus. He Q; Dong M; Pan Q; Wang X; Guo L Minerva Endocrinol; 2019 Sep; 44(3):252-258. PubMed ID: 29687969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]